
Investors should consider Eli Lilly (LLY) as a high-conviction play following its acquisition of Centessa Pharmaceuticals, with its Orexin pathway drugs potentially becoming the next "lifestyle" blockbuster for wakefulness. In the quantum sector, IBM, IonQ (IONQ), and Rigetti (RGTI) are top picks for government-backed growth as the U.S. aggressively funds domestic chip foundries and sensing technology. While OpenAI and SpaceX remain private, investors can gain exposure to the next phase of AI hardware by targeting Intel (INTC) and Google (GOOGL), which are leading the shift toward high-speed Photonic Computing. Monitor SpaceX secondary markets at the $153 price level, as the company's expansion into orbital data centers and cargo retrieval is outpacing traditional cloud providers. For those looking at international AI trends, ByteDance currently leads in video generation, though this poses a significant displacement risk to traditional media and post-production stocks by late 2025.
Based on the podcast transcript, here are the investment insights and asset mentions:
OpenAI is currently navigating significant regulatory hurdles and internal strategic shifts, including a "national security hold" on its latest models.
• GPT-5.6 Release Throttled: The U.S. government has entered the "release loop," restricting the release of GPT-5.6 Sol (flagship), Terra (mid-tier), and Luna (low-cost) to a select group of 20 companies. • Cybersecurity Focus: OpenAI is pivoting from offensive to defensive AI with GPT-5.5 Cyber CodeNate Daybreak, aiming to automatically patch security holes in global infrastructure. • IPO Delay: Leadership is reportedly pulling back on a near-term IPO, preferring to wait until the company can command a valuation exceeding $1 trillion. • Revenue Growth: Despite projected losses of $26 billion this year, revenue is reportedly on a run rate of $40–$50 billion, largely driven by enterprise tools like Codex.
• Valuation Strategy: The delay in IPO suggests OpenAI is prioritizing long-term dominance and "AGI" milestones over immediate public market liquidity. • Enterprise Pivot: Investors should watch for OpenAI’s transition from a consumer-focused company to an enterprise powerhouse, as this is the primary driver for their $1T+ valuation goal.
Anthropic is facing similar regulatory constraints as OpenAI but is actively collaborating with the U.S. government on security.
• Mythos 5 Release: The Trump administration struck a deal to allow the release of the Mythos 5 model to 100 select companies after a national security hold. • Project Glasswing: Anthropic’s internal testing identified vulnerabilities in classified U.S. systems, leading to a ban on foreign nationals accessing the most advanced models. • Corporate Espionage: Anthropic has accused China’s Alibaba of a massive "distillation campaign," allegedly using 25,000 fake accounts to copy Claude’s capabilities.
• Regulatory Moat: Anthropic’s close ties to U.S. intelligence (Project Glasswing) may create a "trust moat," making them a preferred provider for government and highly regulated industries. • IP Risks: The Alibaba accusation highlights the difficulty in protecting AI intellectual property, suggesting that "speed of innovation" is a more viable defense than legal patents.
The discussion highlighted Elon Musk’s expanding "Star" ecosystem and the company's recent successful secondary offerings.
• New Ventures: Musk announced StarMind (orbital AI constellation), Starfall (cargo retrieval), and StarPipe (oil/gas/refining infrastructure). • Financial Performance: SpaceX’s AI-related revenue from its cloud business has reportedly overtaken AWS and Google Cloud in run-rate growth. • Valuation: The company maintains a $200 billion valuation, with recent secondary shares trading around $153.
• Acquisition Rampage: With liquid stock and high valuation, SpaceX is expected to aggressively acquire companies in the photonic computing and satellite sectors. • Orbital Data Centers: There is a strong bullish sentiment toward moving heavy compute to orbit to bypass Earth-based energy and regulatory constraints.
The pharmaceutical giant is applying its successful "receptor agonist" playbook (from weight-loss drugs) to the neuroscience sector.
• Centessa Acquisition: Eli Lilly recently acquired Centessa Pharmaceuticals for $6.3 billion. • Orexin Pathway: The investment focuses on Orexin, a neuropeptide that acts as a master switch for wakefulness. • Lifestyle Potential: While currently for narcolepsy, the panel views this as a future "lifestyle drug" that could allow humans to function optimally on only 4 hours of sleep.
• The "Next GLP-1": Orexin-targeting drugs could be as transformative for Eli Lilly’s stock as their weight-loss drugs (Zepbound/Mounjaro), potentially creating a massive new market for "productivity/wakefulness" enhancement.
The U.S. government is aggressively funding domestic quantum companies to prevent a "Sputnik moment" with China.
• IBM (IBM): Received $1 billion to develop a quantum chip foundry in New York. • D-Wave (QBTS), Rigetti (RGTI), and IonQ (IONQ): Each secured roughly $100 million in government support. • PsyQuantum: Received a $140 million equity stake.
• Sensing vs. Computing: Analysts suggest Quantum Sensing (navigation/detection) and Quantum Photonics may provide faster investment returns than general-purpose quantum computers. • National Security Play: Quantum is now being guarded like "nuclear secrets," suggesting that companies with government contracts have a significant defensive advantage.
• Theme: Moving from electrons to light (photons) for data processing. • Insight: Photonic chips offer 1,000x clock speed improvements and use significantly less power. This is viewed as the "stepping stone" to the next phase of AI hardware. • Key Players Mentioned: Intel (INTC), Google (GOOGL), and Liquid AI.
• Theme: The collapse of traditional media production costs. • Insight: China’s ByteDance (Seedance 2.5) is currently leading in high-fidelity video. The panel predicts real-time 4K video games and AI-generated movies by late 2025. • Risk: Hollywood and traditional post-production industries are considered "at risk" of massive displacement.
• Theme: Nations treating AI as a core utility. • Insight: Countries like Argentina are positioning themselves as "AI-friendly" jurisdictions. Investors should look for "Sovereign AI" plays where nations build their own domestic compute clusters.

By PHD Ventures
Tracking the future of technology and how it impacts humanity. Named by Fortune as one of the “World’s 50 Greatest Leaders,” Peter H. Diamandis, MD, is a founder, investor, advisor, and best-selling author. Join Peter on his mission to uplift humanity through technology. Follow Peter on X - https://x.com/PeterDiamandis